talipexole has been researched along with Hyperprolactinemia in 1 studies
talipexole: dopamine receptor agonist; structure given in first source
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domae, M | 1 |
| Yamada, K | 1 |
| Hanabusa, Y | 1 |
| Matsumoto, S | 1 |
| Furukawa, T | 1 |
1 other study available for talipexole and Hyperprolactinemia
| Article | Year |
|---|---|
Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
Topics: Animals; Azepines; Benzamides; Benzothiazoles; Dopamine Antagonists; Dose-Response Relationship, Dru | 1990 |